← Back to screener

Wave Life Sciences Ltd. WVE

Rank #1844 · Nasdaq · $0.7B market cap
⚠ Going-concern flag — the auditor (KPMG LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
40.8
P/E
-12.0
P/B
-15.32
ROE
127.5%
Op. Margin
-60.0%
Debt Ratio
-299%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -12.0x, P/B -15.32x. Ranks in the top 91% of the universe.

Profitability ★★★☆☆
Average

ROE 127.5%. Ranks in the top 45% of the universe.

Safety ★★★★★
Excellent

Debt ratio -299%. Ranks in the top 5% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★★
Excellent

Revenue growth of 3005.1% year over year. Ranks in the top 0% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2015$0.0B$-0.0B$-0.0B$-0.0B-2351.3-20
2016$0.0B$-0.0B$-0.0B$-0.0B-3548.7-52
2017$0.0B$-0.0B$-0.0B$0.0B-12696.11089
2018$0.0B$-0.1B$-0.1B$0.2B-5102.622
2019$0.0B$-0.1B$-0.1B$0.1B-2630.1160
2020$0.0B$-0.2B$-0.2B$0.1B-1303.4290
2021$0.0B$-0.2B$-0.1B$0.1B-763.9296
2022$0.0B$-0.1B$-0.1B$0.1B-310.1201
2023$0.0B$-0.2B$-0.2B$0.0B-4459.3565
2024$0.0B$-0.2B$-0.2B$0.0B-4459.3700
2025$0.1B$-0.1B$-0.1B$-0.0B-60.0-299

← See the full screener